# US 2024/0285767 A1 · Biodegradable lipids for the delivery of active agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0285767 A1
- Document ID: US20240285767A1
- Status: Published application
- Kind: A1
- Application number: 18/589,636
- Filed: 2024-02-28
- Published: 2024-08-29
- Earliest claimed: 2011-12-07
- Assignees: Alnylam Pharmaceuticals, Inc.
- Applicants: Alnylam Pharmaceuticals, Inc.
- Inventors: Martin MAIER; Muthusamy JAYARAMAN; Akin AKINC; Shigeo MATSUDA; Pachamuthu KANDASAMY; Kallanthottathil G. RAJEEV; Muthiah MANOHARAN; Jayaprakash K. NAIR; Thomas A. BAILLIE
- Web page: https://patentgrep.com/patent/US20240285767A1

## CPC

- A61K 47/18: Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K 9/1272: comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers (lipids as modifying agents {A61K47/543})
- A61K 9/5123: {Organic compounds, e.g. fats, sugars}
- A61K 31/7088: Compounds having three or more nucleosides or nucleotides
- A61K 31/7105: Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
- A61K 31/713: Double-stranded nucleic acids or oligonucleotides
- C07C 31/125: containing five to twenty-two carbon atoms
- C07C 211/09: Diamines
- C07C 211/10: Diaminoethanes
- C07C 211/11: Diaminopropanes
- C07C 217/08: the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
- C07C 229/12: to carbon atoms of acyclic carbon skeletons
- C07C 235/06: having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C 251/38: to carbon atoms of a saturated carbon skeleton
- C07C 323/12: the carbon skeleton being acyclic and saturated
- C07C 323/58: with amino groups bound to the carbon skeleton
- C07C 327/22: having carbon atoms of esterified thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C 327/28: having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
- C07C 327/32: having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
- C07D 207/32: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 233/54: having two double bonds between ring members or between ring members and non-ring members
- C07D 295/08: substituted by singly bound oxygen or sulfur atoms
- C07D 295/12: substituted by singly or doubly bound nitrogen atoms (nitro radicals C07D295/06)
- C07D 295/14: substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D 317/30: Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07F 5/022: {without C-boron linkages}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)

## Abstract

The present invention relates to a cationic lipid having one or more biodegradable groups located in a lipidic moiety (e.g., a hydrophobic chain) of the cationic lipid. These cationic lipids may be incorporated into a lipid particle for delivering an active agent, such as a nucleic acid. The invention also relates to lipid particles comprising a neutral lipid, a lipid capable of reducing aggregation, a cationic lipid of the present invention, and optionally, a sterol. The lipid particle may further include a therapeutic agent such as a nucleic acid.

## Claims

### Claim at position 1

1-30. (canceled)

### Claim 31

A lipid consisting of a protonatable primary group and two hydrophobic tails that are directly bonded to the primary group, wherein
each of the two hydrophobic tails are of the formula -(hydrophobic chain)-(C(O)O)— (hydrophobic chain); and
each of the two hydrophobic tails has a total carbon atom content of from 17 to 26 carbon atoms, wherein
at least one hydrophobic tail is of the formula:
wherein R13 is a C13-C17 alkyl, wherein
the maximum length of R13 from its attachment point to the ester group is 12 carbon atoms, and
R13 comprises (i) a carbon atom that is directly bonded to the ester, (ii) two alkyl groups directly bonded to the carbon atom that is bonded to the ester, and (iii) a hydrogen atom directly bonded to the carbon atom that is bonded to the ester.

### Claim 32 (depends on 31)

The lipid of claim 31, wherein the primary group consists of a head group and a central moiety, the central moiety is a nitrogen atom, and both hydrophobic tails are directly bonded to the central moiety.

### Claim 33 (depends on 32)

The lipid of claim 32, wherein the maximum length of R13 from its attachment point to the ester group is 11 carbon atoms.

### Claim 34 (depends on 32)

The lipid of claim 32, wherein the ester group in each hydrophobic tail is separated from a terminus of the hydrophobic tail by from 8 to 12 carbon atoms.

### Claim 35 (depends on 32)

The lipid of claim 32, wherein R13 is a C17 alkyl.

### Claim 36 (depends on 32)

The lipid of claim 32, wherein the protonatable group is located in the head group.

### Claim 37 (depends on 32)

The lipid of claim 32, wherein the head group consists of a saturated aliphatic group and a hydroxyl group.

### Claim 38 (depends on 37)

The lipid of claim 37, wherein the saturated aliphatic group is a saturated straight chain alkyl group, wherein the saturated straight chain alkyl group is a methyl, ethyl, n-propyl, n-butyl, n-pentyl, or n-hexyl group.

### Claim 39 (depends on 32)

The lipid of claim 32, wherein the ester group in the at least one hydrophobic tail is separated from a terminus of the tail by 6 to 8 carbon atoms.

### Claim 40 (depends on 32)

The lipid of claim 32, wherein the ester group in the at least one hydrophobic tail is separated from a terminus of the tail by 8 carbon atoms.

### Claim 41 (depends on 32)

The lipid of claim 32, wherein the two hydrophobic tails have different chemical formulas.

### Claim 42 (depends on 41)

The lipid of claim 41, wherein both hydrophobic tails have a chain length of 18 atoms.

### Claim 43 (depends on 42)

The lipid of claim 42, wherein, in the other hydrophobic tail, each hydrophobic chain is a saturated straight chain alkyl group.

### Claim 44 (depends on 43)

The lipid of claim 43, wherein the other hydrophobic tail has a total carbon content of 17 carbon atoms.

### Claim 45 (depends on 32)

The lipid of claim 32, wherein a protonatable group of the protonatable primary group is positively charged at a pH that is below pH 7.4, and neutral at a second pH that is at or above pH 7.4.
